ZA813866B - Antitumor compositions - Google Patents
Antitumor compositionsInfo
- Publication number
- ZA813866B ZA813866B ZA00813866A ZA813866A ZA813866B ZA 813866 B ZA813866 B ZA 813866B ZA 00813866 A ZA00813866 A ZA 00813866A ZA 813866 A ZA813866 A ZA 813866A ZA 813866 B ZA813866 B ZA 813866B
- Authority
- ZA
- South Africa
- Prior art keywords
- amsa
- antitumor compositions
- acridinylamino
- anisidide
- methanesulfon
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/455—Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Hematology (AREA)
- Biochemistry (AREA)
- Oncology (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pyridine Compounds (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US15678880A | 1980-06-12 | 1980-06-12 |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA813866B true ZA813866B (en) | 1982-06-30 |
Family
ID=22561097
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA00813866A ZA813866B (en) | 1980-06-12 | 1981-06-09 | Antitumor compositions |
Country Status (8)
Country | Link |
---|---|
EP (1) | EP0042553B1 (xx) |
JP (2) | JPS5728006A (xx) |
AT (1) | ATE15602T1 (xx) |
AU (1) | AU542346B2 (xx) |
CA (1) | CA1188223A (xx) |
DE (1) | DE3172317D1 (xx) |
NZ (1) | NZ197116A (xx) |
ZA (1) | ZA813866B (xx) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1984001506A1 (en) * | 1982-10-13 | 1984-04-26 | Univ Birmingham | Pharmaceutical preparations for use in antitumour therapy |
US4575509A (en) * | 1983-01-31 | 1986-03-11 | Bristol-Myers Company | Water-soluble formulations of m-AMSA with pyroglutamic acid |
US4626541A (en) * | 1985-09-12 | 1986-12-02 | Bristol-Myers Company | Water soluble salt composition of m-AMSA |
KR20210092204A (ko) * | 2018-10-04 | 2021-07-23 | 레이스 온콜로지 리미티드 | 비산트렌 제형의 제조 및 전달을 위한 방법 |
AU2022390813A1 (en) * | 2021-11-18 | 2024-06-13 | Onconova Therapeutics, Inc. | Methods and compositions for treating cancer |
WO2024107955A1 (en) * | 2022-11-17 | 2024-05-23 | Onconova Therapeutics, Inc. | Methods and compositions for treating cancer |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2010007871A (ja) * | 2008-06-24 | 2010-01-14 | Daikin Ind Ltd | 換気装置 |
-
1981
- 1981-05-15 NZ NZ197116A patent/NZ197116A/en unknown
- 1981-05-19 AU AU70837/81A patent/AU542346B2/en not_active Ceased
- 1981-05-22 CA CA000378081A patent/CA1188223A/en not_active Expired
- 1981-06-08 JP JP8702381A patent/JPS5728006A/ja active Granted
- 1981-06-09 ZA ZA00813866A patent/ZA813866B/xx unknown
- 1981-06-11 AT AT81104513T patent/ATE15602T1/de not_active IP Right Cessation
- 1981-06-11 EP EP81104513A patent/EP0042553B1/en not_active Expired
- 1981-06-11 DE DE8181104513T patent/DE3172317D1/de not_active Expired
-
1988
- 1988-06-02 JP JP63134549A patent/JPS6413025A/ja active Granted
Also Published As
Publication number | Publication date |
---|---|
DE3172317D1 (en) | 1985-10-24 |
NZ197116A (en) | 1984-03-16 |
AU7083781A (en) | 1981-12-17 |
JPH0343251B2 (xx) | 1991-07-01 |
EP0042553B1 (en) | 1985-09-18 |
JPH0149693B2 (xx) | 1989-10-25 |
ATE15602T1 (de) | 1985-10-15 |
EP0042553A1 (en) | 1981-12-30 |
JPS6413025A (en) | 1989-01-17 |
JPS5728006A (en) | 1982-02-15 |
CA1188223A (en) | 1985-06-04 |
AU542346B2 (en) | 1985-02-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE3172317D1 (en) | Antitumor compositions | |
EP0184258A3 (en) | Novel derivatives of hydroxy- or amino-substituted (piperidinylalkyl)quinazolines | |
ES453161A1 (es) | Un procedimiento de preparacion de espiro (1,3-dioxolan-4,3)quinuclidinas. | |
SE8103071L (sv) | Antitumorkompositioner samt sett att framstella dessa | |
GR75945B (xx) | ||
GB1379111A (en) | Preparation of fused-ring pyridine and pyrazine derivatives | |
IL71339A0 (en) | Penem compounds,methods for their preparation and pharmaceutical compositions containing them | |
ES470274A1 (es) | Procedimiento de preparacion de nuevos derivados de benzo- (b)-tienopiridinas | |
GB1278272A (en) | Substituted hexahydro-imidazoquinolines | |
GB1436080A (en) | Ellipticine derivative and pharmaceutical uses thereof | |
IE55974B1 (en) | Anthracycline glycosides,their manufacture and medicaments containing them | |
ES8700650A1 (es) | Procedimiento para preparar derivados de acidos 7-(ariloxi)-2-naftiloxi-alcancarboxilicos racemicos e isomeros | |
IL59253A (en) | 2-amino-8-cyclopropyl-5-oxo-5,8-dihydro-pyrido(2,3-d)-pyrimidine-6-carboxylic acid compounds,their production and pharmaceutical and feed compositions containing them | |
JPS5225740A (en) | Preparation of o-acyl-amidinophenols or acid addition salts thereof | |
ES483087A1 (es) | Procedimiento para la obtencion de bencimidazolcarbamatos | |
ES8202332A1 (es) | Un metodo para la preparacion de sales de 4'-(9-acridinila- mino)-metanosulfon-m-anisidida | |
US4835182B1 (xx) | ||
ES409196A1 (es) | Procedimiento para la obtencion de sales de adicion de aci-do de derivados de indenopiridina. | |
IE41017L (en) | Thionophosphoric acid ester | |
EP0087951A3 (en) | Phenanthroline derivatives | |
JPS5277094A (en) | Preparation of 1, n6-etheno-2-hydroxy-adenosine-3#, 5#-cyclic phosphor ic acid | |
JPS5219647A (en) | Preparation of 3-aminomethyl-4- homoisotwistane and its acid addition salt | |
IL49720A0 (en) | 6-(alpha-amino-omega-(2,3-methylenedioxyphenyl)-acylamido)penicillanic acid derivatives | |
JPS5262292A (en) | Preparation of cephalosporin compounds | |
GB1266646A (xx) |